glp-1 drugs manufacturers suppliers distributors 2023-2025 Must Adapt to Growing and GIP/GLP-1 RA Markets GLP-1 Receptor Agonist Shortage: Challenges

For example, one study showed people on Ozempic are 30% less likely to become addicted to nicotine 1

Clinical Applications Type 2 Diabetes Management Glucagon-like peptide-1 (GLP-1) agonists have emerged as a crucial class of medications for managing type 2 diabetes, a chronic condition characterized by insulin resistance and impaired glucose regulation

This is particularly valuable for teams in health economics and outcomes research (HEOR), epidemiology, and pharmacovigilance who are tasked with evaluating real-world performance

Our clinical analysis revealed a modest increase in the incidence of DR but a lower risk of progression to sight-threatening disease in patients with preexisting DR

doi: 10.1056/NEJMoa2401943 204 SkovJDejgaardAFrkirJHolstJJJonassenTRittigSet al

Fisman, E